Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2019-04-22 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. S. N. Ananthasubramanian & Co., Company ....
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31st March 2019. It is a compliance certificate from a company secretary firm regarding share transfer forms and related documents. The document does not contain financial statements or detailed financial analysis, nor is it an announcement of a report. It is a regulatory compliance certificate related to share transfer processes. Such certificates fall under Regulatory Filings (RNS) as they are compliance documents and do not fit into other specific categories like Annual Report, Interim Report, or Audit Report.
2019-04-22 English
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document text is extremely short (63 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement of a report. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2019-04-22 English
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2019 ,inter alia, to consider and approve unaudited financial results for ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board of Directors meeting scheduled for May 7, 2019. The purpose of the meeting includes consideration of unaudited financial results for the quarter ended March 31, 2019. The document references a future event and does not contain actual financial data or detailed financial statements. It is a regulatory announcement pursuant to SEBI regulations about the meeting date and agenda, not the financial report itself. The document length is short (851 characters), and it serves as a notification rather than a report. Therefore, it fits best under Regulatory Filings (RNS).
2019-04-22 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates ....
Regulatory Filings Classification · 95% confidence The document is a short notification addressed to stock exchanges regarding the issuance of duplicate share certificates due to loss or misplacement. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate management. The content is an announcement of a corporate action related to share certificates, not a financial report, management change, or voting result. It does not contain financial data or detailed report content. Given the short length (1307 characters) and the nature of the content, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-04-16 English
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the shareholding of persons acting in concert and promoters holding more than 25% voting rights in Sanofi India Limited. The content focuses on shareholding percentages and related information, which aligns with notifications about major shareholding changes. There is no indication of financial statements, audit information, or management commentary. The document is not a report but a regulatory disclosure about shareholding levels crossing thresholds. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length and detail support a high confidence score.
2019-04-16 English
Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the compliance certificate for the period 1st October 2018 ....
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It confirms compliance related to share transfer facilities for the period 1st October 2018 to 31st March 2019. The document is short (1814 characters) and primarily serves as a certification letter rather than a full financial or operational report. It does not contain financial statements or detailed analysis but is an attestation of compliance. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2019-04-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.